| BCBS Florida Coverage Guidelines | Lumasiran (Oxlumo) injection (09-J3000-91) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Luspatercept-aamt (Reblozyl®) Injection (09-J3000-61) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Mirikizumab-mrkz (Omvoh®) Injection and (09-J4000-71) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Nemolizumab-ilto (Nemluvio) Injection (09-J4000-99) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Nivolumab products (Opdivo®, Opdivo (09-J2000-33) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Nivolumab; Relatlimab-rmbw (Opdualag) (09-J4000-23) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Octreotide Acetate (Sandostatin LAR® Depot) (09-J0000-90) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Oncology Self-administered Medications (09-J3000-65) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Ozanimod (Zeposia®) Capsules (09-J3000-70) | 2026-07-01 |
| BCBS Florida Coverage Guidelines | Pegloticase (Krystexxa®) Infusion (09-J3000-29) | 2026-07-01 |